Navigation Links
Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
Date:6/29/2009

president and chief executive officer of Horizon Therapeutics. "Dr. Sherman will oversee the preparation and submission of the HZT-501 regulatory applications to U.S. and European regulatory authorities, while helping us manage the clinical development of our other pain therapies."

In addition to his Horizon appointment, Dr. Sherman was recently elected President of the Drug Information Association (DIA), a global, nonprofit, multidisciplinary, professional association of approximately 18,000 members which provides a neutral forum for sharing information that optimizes the process of drug development and lifecycle management. He has been a member of the DIA Board of Directors for nearly seven years and in 2001, received the association's "Outstanding Service Award."

About Horizon Therapeutics

Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the company and its products, please visit www.horizontherapeutics.com.


'/>"/>
SOURCE Horizon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AGA Institute and Horizon Therapeutics Launch Connect to Protect Program to Educate Physicians and Consumers on Risks Associated With NSAID Use
2. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
3. Horizon Therapeutics Announces Senior Management Appointments
4. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
5. Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
6. Horizon Therapeutics to Present at UBS Global Life Sciences Conference
7. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
8. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
9. BioHorizons Announces the Purchase of Implant Logic Systems
10. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
11. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 Histogen, Inc., ... products of cells grown under simulated embryonic conditions, today ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic products ... , This agreement is an amendment to the ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... 14, 2014 iLab Solutions, the leader in ... new Director of Product Strategy. In this role, Michelle will ... sub-teams to guide in the development of iLab products. Her ... maximum possible benefit to the scientific community by offering the ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Highlighted by Cinryze(TM) [C1 Inhibitor (human)] Commercial Launch --EXTON, Pa., ... reported today its financial results for the fourth quarter and ... include:Operational: , , , ... Inc. (Lev) in October 2008; , ...
... Feb. 24 Mach One Corporation (Pink Sheets: MNCN), ... purchase of Ceres Organic Harvest, Inc. an organic grain ... feed and dairy industries. Ceres Organic Harvest had 2008 ... the stock of Ceres for $8 million in a ...
... (USA) Inc ("MINDSET") a company privately held by MPM ... received a Notice of Allowance in Europe related to ... for the prevention and treatment of memory loss. Drugs ... been approved for the treatment of type II diabetes ...
Cached Biology Technology:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 2ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 3ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 4ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 5ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 6ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 7ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 8ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 9ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 10ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 11ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results 12Mach One Corporation Completes Acquisition of Ceres Organic Harvest, Inc. 2Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss 2Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss 3
(Date:4/16/2014)... The "brush border" a densely packed array of ... the cells that line our intestines., Vanderbilt University researchers ... structure, which is critical for absorbing nutrients and defending ... journal Cell , reveal a role for adhesion ...
(Date:4/16/2014)... thoughts and feelings are the result of neurons talking ... of the conversations might not be all that private. Brain ... even participating in, some of those discussions. But a new ... part of the time specifically, when the neurons get ...
(Date:4/16/2014)... to conquer the world? Surprisingly, bacteria also face this ... now shown how these organisms should decide how best ... subtilis is quite adaptable. It moves about in ... Alternatively, it can stick to an underlying substrate. Actually, ...
Breaking Biology News(10 mins):Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3Eavesdropping on brain cell chatter 2Eavesdropping on brain cell chatter 3Theoretical biophysics: Adventurous bacteria 2
... German . , Tobias Brgmann and his colleagues from the ... for their experiments, which is a type of light sensor. At ... the cell membrane. When stimulated with blue light, this channel opens, ... in the cell membrane,s pressure, which stimulates cardiac muscle cells to ...
... towards the poles almost everywhere in the world, except ... and snails Steffen Kiel and Sven Nielsen at the ... pattern originated at the end of the last ice ... created a mosaic landscape of countless islands, bays and ...
... rich in walnuts and walnut oil may prepare the body ... Penn State researchers who looked at how these foods, which ... stress., Previous studies have shown that omega-3 fatty acids -- ... seeds -- can reduce low density lipoproteins (LDL) -- bad ...
Cached Biology News:Bonn researchers use light to make the heart stumble 2Disappearing glaciers enhanced biodiversity 2Walnuts, walnut oil, improve reaction to stress 2Walnuts, walnut oil, improve reaction to stress 3
Request Info...
... Source: E. coli containing a clone of ... Description: Topoisomerase II alters the topological state ... helix through a transient break which generates a ... of its double-stranded DNA passage mechanism, the enzyme ...
Request Info...
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Biology Products: